Maren Altman, a 27-year-old astrologer and content creator, has made a courageous revelation regarding her health through a recent Instagram post. In an emotional video, she disclosed that she has tested positive for the C9ORF72 genetic mutation, which is linked to conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although she is currently without symptoms, Altman is acutely aware that her family history puts her at a significantly increased risk for developing one of these devastating neurodegenerative diseases.
:max_bytes(150000):strip_icc():format(jpeg)/Maren-Altman-062526-a4f8adb35d72458a858aa45626d3704c.jpg)
In her Instagram Reel, Altman detailed the gravity of her diagnosis, stating, “I was recently confirmed to have inherited the fatal, incurable brain disease caused by the C9ORF72 mutation. I’m currently entirely presymptomatic, and I’m not going to have clinical symptoms for a while, but I am almost guaranteed to get frontotemporal dementia, ALS, or both in my 40s based on my family history.” This candid admission sheds light on the emotional turmoil experienced when grappling with her genetic legacy.
The impetus for testing came from Altman’s family history, marked by early-onset neurological illnesses, particularly her mother’s struggle with FTD, which commenced in her early 40s. Altman explained that witnessing her family face these heart-wrenching conditions prompted her to seek testing, stating, “I got tested because my mom had FTD onset in her early 40s, which matched her mother’s early Alzheimer’s timeline.”
Despite leading a lifestyle focused on health, she emphasised the limitations of lifestyle choices in altering genetic predisposition. Altman remarked, “Being vegan and straight edge and really healthy for literally basically my whole life has no impact on this. Lifestyle cannot change a massive cellular mutation that started in conception.” This highlights a belief that some medical realities are beyond individual control, regardless of how diligently one maintains their health.
The C9ORF72 repeat expansion is noted as the most prevalent known inherited cause of ALS and frontotemporal dementia within medical literature, according to the National Library of Medicine. Thus, Altman’s disclosure is not only significant for her own narrative but also raises awareness about the mutation and its implications for families affected by these illnesses.
Additionally, Altman reflected on the emotional implications of potentially passing the mutation to her future children. She candidly shared, “I never wanted kids, but there is a gravity to knowing that it’s an ethical necessity to be a biological dead end.” Though not everyone who carries the mutation will go on to develop the associated diseases and the age of onset can differ widely, family history remains a critical factor in assessing risk.
As part of her proactive approach to her diagnosis, Altman is also contemplating end-of-life planning in advance of any potential onset of symptoms. She mentioned a desire for “dignity” as a primary concern. She stated, “Being 27 and having to already think about these advanced directives is quite sad.” This stark recognition of her circumstances adds a layer of complexity to her personal journey, as she copes with decisions that many do not consider until later in life.
When discussing her preferences regarding the progression of these potential conditions, Altman expressed a wish to have ALS over frontotemporal dementia, stating, “I would rather lose my body quickly than my mind slowly.” This poignant commentary emphasises the profound fear many have regarding cognitive decline and its impact on quality of life.
In sharing her story, Maren Altman is not only addressing her own future but also engaging in a larger dialogue about genetic diseases, their implications, and the difficult choices that can accompany such diagnoses. By opening up about her experiences, she may provide support and inspiration to others grappling with similar health uncertainties. The tale of her diagnosis is one of resilience in the face of adversity, highlighting the importance of awareness and discussion surrounding genetic disorders.